Share Price

Specialty Chemicals company Gem Aromatics announced Q3FY26 results Revenue: Rs 78.9 crore against Rs 96.8 crore during Q3FY25, change -18%. EBITDA: Rs 7 crore against Rs 13 crore during Q3FY25, change -46%. EBITDA Margin: 8.9% for Q3FY26. PBT: Rs 18.2 crore against Rs 25 crore during Q3FY25, change -27%. PBT Margin: 23% for Q3FY26. PAT: Rs -5 crore against Rs 7.5 crore during Q3FY25, change -167%. PAT Margin: -6.3% for Q3FY26. EPS: Rs -1.04 for Q3FY26. Yash Vipul Parekh, MD & CEO, said: During Q3FY26, the Company commissioned WS 23 & WS 03 cooling agents, along with Clove Oil and Eugenol, at its greenfield Dahej plant, marking an important operational milestone. The total capital expenditure for the facility is approximately Rs 270 crore, of which around Rs 250 crore has already been incurred and largely capitalised. The plant has been developed in accordance with international standards for quality, equipment, and technology. The plant is currently in the stabilization phase and has successfully completed the first stage audits for FSSC 22000 Version 6, GHP, HACCP, ISO 9001 2015, ISO 14001 2015, and ISO 45001 2018. Gross margins have improved and are trending towards normal levels, and EBITDA margins have also shown improvement, supported by a gradual recovery in mint prices and improved customer blending alignment, which led to better order inquiries during Q3FY26. Non-mint products such as clove and its derivatives continued to grow in line with the Company’s diversification strategy. However, revenues remained impacted by external headwinds, including tariff-related uncertainty and GST-related changes. Looking ahead, the Company continues to advance its product pipeline. Pilot trials for Citral derivatives, including Safranal and Damascones, have been completed. For Phenol derivatives, catalyst preparation is underway and is expected to be completed by the end of Q4FY26, with trial production planned from Q1FY27. These initiatives are supporting a gradual reduction in dependence on Mint and Mint derivatives. With an expanding product portfolio, improving asset utilisation, and a continued focus on innovation and sustainability, the Company remains well positioned to drive long-term value creation and is targeting revenue of Rs 1,050 - 1,100 crore by FY28, with EBITDA margins of 16 -18%. Result PDF

• Trendlyne
• 4 months 2 weeks ago

The initial public offer of speciality ingredients manufacturer Gem Aromatics Ltd got subscribed 30.27 times on the last day of share sale on Thursday. The IPO received bids for 29,61,15,202 shares against 97,82,363 shares on offer, as per NSE data. Qualified Institutional Buyers (QIBs) part got subscribed 55.28 times, while the category for non-institutional investors received 45.06 times subscription. The quota for Retail Individual Investors (RIIs) fetched 10.31 times subscription. Gem Aromatics on Monday mobilised over Rs 135 crore from anchor investors. The price band has been fixed at Rs 309 to Rs 325 per share. The IPO is a mix of fresh issue of equity shares worth up to Rs 175 crore and an offer for sale (OFS) of up to 85 lakh shares valued at Rs 276.25 crore. Proceeds from the fresh issue will be used by Gem Aromatics for debt repayment and general corporate purposes. Gem Aromatics is a manufacturer of speciality ingredients, including essential oils, aroma chemicals, a

• Business Standard
• 10 months ago

Gem Aromatics IPO Live Updates: Gem Aromatics intends to fulfill prepayment or repayment for all or a portion of certain outstanding borrowings.

• NDTV Profit
• 10 months ago